A TAILORx analysis shows women with early-stage breast cancer and high recurrence scores on the Oncotype DX who received chemotherapy with hormone therapy had better long-term outcomes than what would be expected from hormone therapy alone.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/31Ip2re
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/31Ip2re